Kymera Therapeutics KYMR
NASDAQ KYMR
$134.84 -1.80 (-1.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Kymera Therapeutics (KYMR) Long-Term Debt Repayments (2019 - 2026)

Updated

Analysis

Kymera Therapeutics (KYMR) Long-Term Debt Repayments (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Kymera Therapeutics 11.66 Bn 8.50 Bn - -444,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -444,000.00
Jun 30, 2026 -436,000.00
Mar 31, 2026 -425,000.00
Dec 31, 2025 -416,000.00
Sep 30, 2025 -419,000.00
Jun 30, 2025 -382,000.00
Mar 31, 2025 -277,000.00
Dec 31, 2024 -293,000.00
Sep 30, 2024 -641,000.00
Jun 30, 2024 -352,000.00
Mar 31, 2024 -290,000.00
Dec 31, 2023 925,000.00
Sep 30, 2023 -340,000.00
Jun 30, 2023 -334,000.00
Mar 31, 2023 -327,000.00
Dec 31, 2022 -305,000.00
Sep 30, 2022 -292,000.00
Jun 30, 2022 -269,000.00
Mar 31, 2022 -264,000.00
Dec 31, 2021 -156,000.00
API Access

Kymera Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=KYMR&period=max&api_key=YOUR_API_KEY